Brain training activity linked to reduced dementia risk

by Alzheimer's Research UKFlorida researchers have presented results from a 10-year study into the effects of 'brain training' activities on healthy older people. The study found that

Updated on: March 07,2024

Brain training activity linked to reduced dementia risk

by Alzheimer's Research UKFlorida researchers have presented results from a 10-year study into the effects of 'brain training' activities on healthy older people. The study found that

Updated on:March 07,2024

Biogen cuts the price tag on its Alzheimer's drug in half

by Tom MurphyThe Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread critic

Updated on: April 25,2024

Biogen cuts the price tag on its Alzheimer's drug in half

by Tom MurphyThe Biogen Inc., headquarters is shown March 11, 2020, in Cambridge, Mass. Biogen is slashing the price of its Alzheimer's treatment months after the drug debuted to widespread critic

Updated on:April 25,2024

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on: March 30,2024

FDA approves first drug meant to ease Alzheimer's-linked agitation

by Cara MurezA medication to treat agitation in Alzheimer's patients now has approval from the U.S. Food and Drug Administration.The FDA gave supplemental approval to Otsuka Pharmaceutical Company

Updated on:March 30,2024

Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefits

byNiigata UniversityL-arginine inhibits the aggregation of polyglutamine proteins in neuronal cells. Credit: Niigata UniversityA team has conducted a trial on the efficacy and safety of L-argini

Updated on: December 18,2024

Clinical trial suggests new drug candidate for spinocerebellar ataxia may offer certain therapeutic benefits

byNiigata UniversityL-arginine inhibits the aggregation of polyglutamine proteins in neuronal cells. Credit: Niigata UniversityA team has conducted a trial on the efficacy and safety of L-argini

Updated on:December 18,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on: April 01,2024

Successful Phase 2 clinical trial for neflamapimod in mild-to-moderate Lewy body dementia

by University of North Carolina at Chapel Hill School of MedicineCredit: CC0 Public DomainEIP Pharma announced on October 6 that a phase 2 study in patients with mild-to-moderate Lewy body dement

Updated on:April 01,2024

Neuroscientist uses AI to map learning, decision-making, to discover how brains work

by Stacey DeLoye,University of FloridaMeta-learning of RL. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41593-023-01485-3With trial and error, repetition and praise, when a puppy

Updated on: March 13,2024

Neuroscientist uses AI to map learning, decision-making, to discover how brains work

by Stacey DeLoye,University of FloridaMeta-learning of RL. Credit:Nature Neuroscience(2023). DOI: 10.1038/s41593-023-01485-3With trial and error, repetition and praise, when a puppy

Updated on:March 13,2024

Care more expensive for dementia patients and families in last years of life

by The Mount Sinai HospitalThe cost of care over the last five years of life for patients with dementia is significantly higher than for patients who die from heart disease, cancer, or other caus

Updated on: February 26,2024

Care more expensive for dementia patients and families in last years of life

by The Mount Sinai HospitalThe cost of care over the last five years of life for patients with dementia is significantly higher than for patients who die from heart disease, cancer, or other caus

Updated on:February 26,2024

Investigating specific pathological features of cerebral cavernous malformation in children

by Katie Paradis,Children's Hospital BostonCredit: CC0 Public DomainChildren with cavernous malformations face unique treatment challenges due to factors such as the malformation's locat

Updated on: November 28,2024

Investigating specific pathological features of cerebral cavernous malformation in children

by Katie Paradis,Children's Hospital BostonCredit: CC0 Public DomainChildren with cavernous malformations face unique treatment challenges due to factors such as the malformation's locat

Updated on:November 28,2024

Deaths from Alzheimer's disease in Scotland increase by 33.4% in one year

by Alzheimer's Research UKDeaths from Alzheimer's in Scotland have soared by 33.4 percent in a year, according to new statistics released by the National Records of Scotland today.Provisi

Updated on: March 07,2024

Deaths from Alzheimer's disease in Scotland increase by 33.4% in one year

by Alzheimer's Research UKDeaths from Alzheimer's in Scotland have soared by 33.4 percent in a year, according to new statistics released by the National Records of Scotland today.Provisi

Updated on:March 07,2024

Genetic 'hotspots' that speed up and slow down brain aging could provide new targets for Alzheimer's drugs

by University of Southern CaliforniaCredit: CC0 Public DomainResearchers from a USC-led consortium have discovered 15 "hotspots" in the genome that either speed up brain aging or slow i

Updated on: June 20,2024

Genetic 'hotspots' that speed up and slow down brain aging could provide new targets for Alzheimer's drugs

by University of Southern CaliforniaCredit: CC0 Public DomainResearchers from a USC-led consortium have discovered 15 "hotspots" in the genome that either speed up brain aging or slow i

Updated on:June 20,2024

Genetic and non-genetic resilience against memory decline and Alzheimer's

by Alzheimer's Research UKResearchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer's, while others don't. At AAIC2016,

Updated on: March 07,2024

Genetic and non-genetic resilience against memory decline and Alzheimer's

by Alzheimer's Research UKResearchers across the world are keen to understand why some people experience memory decline or diseases like Alzheimer's, while others don't. At AAIC2016,

Updated on:March 07,2024

Can slow walking speed in elderly signal Alzheimer's disease hallmarks?

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.How fast elderly people walk may be related to the amount of amyloid

Updated on: February 27,2024

Can slow walking speed in elderly signal Alzheimer's disease hallmarks?

by American Academy of NeurologyDiagram of the brain of a person with Alzheimer's Disease. Credit: Wikipedia/public domain.How fast elderly people walk may be related to the amount of amyloid

Updated on:February 27,2024